SCHEMBL2089634

SCHEMBL2089634

Nc1ccc(O)nc1N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9794284 0.78
SCHEMBL5925818 0.74
SCHEMBL12618144 0.74
SCHEMBL508538 0.74
SCHEMBL29655658 0.71
SCHEMBL2419335 0.71
SCHEMBL13222949 0.69 MAPT (0.38)
SCHEMBL4635194 0.69 NAPRT (0.48)
SCHEMBL30259108 0.69 ALDH1A1 (0.35)
Hydrochloric Acid SCHEMBL29259777 0.69 MEN1 (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1576093-A4 3-DEOXYGLUCOSONE AND SKIN DYNAMIS THERAPEUTICS INC (US) 2009-07-08 EP claimed
US-20070065443-A1 Fructoseamine 3 kinase and the formation of collagen and elastin DYNAMIS THERAPEUTICS, INC. 2007-03-22 US claimed
EP-1753861-A2 FRUCTOSEAMINE 3 KINASE AND THE FORMATION OF COLLAGEN AND ELASTIN Dynamis Therapeutics, Inc. (US) 2007-02-21 EP claimed
EP-1576093-A2 3-DEOXYGLUCOSONE AND SKIN Dynamis Therapeutics, Inc. (US) 2005-09-21 EP claimed
WO-2005079463-A2 FRUCTOSEAMINE 3 KINASE AND THE FORMATION OF COLLAGEN AND ELASTIN DYNAMIS THERAPEUTICS, INC. (US) 2005-09-01 WO claimed
US-20050159383-A1 Administering enzyme inhibitors; wrinkling and aging resistance; prevents formation Advanced Glycation End Products (AGEs) DYNAMIS THERAPEUTICS, INC. 2005-07-21 US claimed
US-20030219440-A1 3-deoxyglucosone and skin DYNAMIS THERAPEUTICS, INC. 2003-11-27 US claimed
WO-2003089601-A2 3-DEOXYGLUCOSONE AND SKIN DYNAMIS THERAPEUTICS, INC. (US) 2003-10-30 WO claimed
CN-118908887-A Preparation method and intermediate of 2-amino-6-hydroxypyridine compound 上海凌凯科技股份有限公司 2024-11-08 CN disclosed
CN-109535403-B Preparation method of polyarylate based on 2- (3-carboxyphenyl) -6-hydroxypyridoimidazole 宁波聚嘉新材料科技有限公司 2021-10-12 CN disclosed
CN-110317323-B Preparation method of polyarylate based on 2- (3-carboxyl-4-methoxyphenyl) -6-hydroxypyridoimidazole 浙江甬仑聚嘉新材料有限公司 2021-04-13 CN disclosed
CN-110317323-A The preparation method of polyarylate of the one kind based on 2- (3- carboxyl -4- methoxyphenyl) -6- pyridone and imidazoles 浙江甬仑聚嘉新材料有限公司 2019-10-11 CN disclosed
CN-109535403-A The preparation method of polyarylate of the one kind based on 2- (3- carboxyl phenyl) -6- pyridone and imidazoles 宁波聚嘉新材料科技有限公司 2019-03-29 CN disclosed
CN-101084235-B 3-deoxyglucosone and skin DYNAMIS THERAPEUTICS INC 2012-10-17 CN disclosed
US-20030219440-A1 3-deoxyglucosone and skin DYNAMIS THERAPEUTICS, INC. 2003-11-27 US disclosed
WO-2003089601-A2 3-DEOXYGLUCOSONE AND SKIN DYNAMIS THERAPEUTICS, INC. (US) 2003-10-30 WO disclosed
EP-1175155-A1 METHOD FOR REDUCING A SUSCEPTIBILITY TO TUMOR FORMATION INDUCED BY 3-DEOXYGLUCOSONE AND PRECURSORS THEREOF FOX CHASE CANCER CENTER (US) 2002-01-30 EP disclosed
WO-2000062626-A1 METHOD FOR REDUCING A SUSCEPTIBILITY TO TUMOR FORMATION INDUCED BY 3-DEOXYGLUCOSONE AND PRECURSORS THEREOF FOX CHASE CANCER CENTER (US) 2000-10-26 WO disclosed
WO-1993013775-A1 DIAMINOPYRIDINE COMPOUNDS FOR THE INHIBITION OF PROTEIN GLYCOSYLATION THE ROCKEFELLER UNIVERSITY (US) 1993-07-22 WO disclosed
US-5221683-A Inhibiting advanced clycosylation of target protein THE ROCKEFELLER UNIVERSITY (US) 1993-06-22 US disclosed